Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer-Reference-Cited by-同舟云学术

Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer

Published:2010 Issue: Volume: Page:n/a-n/a
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Santini Daniele,Vincenzi Bruno,Fratto Maria Elisabetta,Perrone Giuseppe,Lai Raymond,Catalano Vincenzo,Cass Carol,Ruffini Pier Adelchi,Spoto Chiara,Muretto Pietro,Rizzo Sergio,Muda Andrea Onetti,Mackey John R.,Russo Antonio,Tonini Giuseppe,Graziano Francesco

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference28 articles.

1. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells;Cai;Cancer Res,2008

2. Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells;Cano-Soldado;Biochem Pharmacol,2008

3. Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry;Chow;Mod Pathol,2005

4. Regression models and life tables;Cox;J R Stat Soc,1972

5. Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers;Dabbagh;Clin Cancer Res,2003

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CamoTSS: analysis of alternative transcription start sites for cellular phenotypes and regulatory patterns from 5' scRNA-seq data;Nature Communications;2023-11-09

2. Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development;Clinical Pharmacology & Therapeutics;2023-07-21

3. Prognostic biomarkers and molecular pathways mediating Helicobacter pylori–induced gastric cancer: a network-biology approach;Genomics & Informatics;2023-03-31

4. Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer;Cancer Cell International;2022-09-01

5. RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin;BMC Cancer;2021-08-05